HKSE · 1681.HK
Consun Pharmaceutical Group Limited
HK$15.49+HK$0.35 (+2.31%)
Consun Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 20.52% below the high.
Loading market information…
HKSE · 3839.HK · HKD
Stock price, earnings
Quote as of Oct 29, 2026, 07:43 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
CPBIO Holding Company Limited’s quoted price sits in the upper half of its reported 52-week range, 21.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CPBIO Holding Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
HK$15.49+HK$0.35 (+2.31%)
Consun Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 20.52% below the high.
HK$2.60+HK$0.02 (+0.78%)
SSY Group Limited’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
HK$3.00+HK$0.09 (+2.92%)
Tong Ren Tang Technologies Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.49% below the high.
HK$2.24-HK$0.03 (-1.11%)
Hua Medicine (Shanghai) Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.27% below the high.
HK$2.70+HK$0.01 (+0.37%)
Jilin Province Huinan Changlong Bio-pharmacy Company Limited’s quoted price sits in the upper half of its reported 52-week range, 10.0% below the high.
HK$5.53-HK$0.11 (-1.87%)
CF PharmTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.01% below the high.
HK$0.92-HK$0.02 (-1.6%)
Dawnrays Pharmaceutical (Holdings) Limited’s quoted price sits in the lower half of its reported 52-week range, 26.4% below the high.
HK$1.06HK$0.00 (0.0%)
Lee's Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.72% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
